---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-011822"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:33:03.033055+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ANI Pharma proposes $250M convertible notes due 2029; to repay term loan

## Summary
- Offering $250M in Convertible Senior Notes due Sept 1, 2029; underwriters option for additional $37.5M.
- Proceeds used to repay existing senior secured term loan; new $325M delayed draw term loan and $75M revolver planned.
- Capped call transactions expected to reduce dilution on conversion of notes.
- Interest rate, conversion rate, and other terms to be set at pricing.
- Notes unsecured; redemption at ANI's option after Sept 1, 2027 under certain conditions.

## SEC filing metadata
- accession: 0000950103-24-011822
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000095010324011822/0000950103-24-011822-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000095010324011822/dp216241_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-011822
- JSON: https://secwatch.observer/filing/0000950103-24-011822.json
- Plain text: https://secwatch.observer/filing/0000950103-24-011822.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.